Steven N. Goodman

Steven N Goodman
Citizenship American
Fields Medical Research, Epidemiology, Medical Statistics
Education AB, Harvard College, Biochemistry, Applied Math (1976)
Alma mater Harvard University
New York University;
Thesis  (1989)
Known for "Cancer research: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents". 

Steven N. Goodman is an American Professor of Medicine and of Health Research and Policy (Epidemiology) at Stanford School of Medicine.[1] He has extensively contributed to statistics and probability analysis within the biosciences, and in 1999 he coined the term "p-value fallacy".[2]

Life

He graduated with an AB (Bachelor of Arts) from Harvard College in 1976, majoring in in Biochemistry and Applied Math. He received an MD from New York University in 1981, completed a pediatrics residency at Washington University in St. Lous, qualified as a Pediatrician in 1985, received an MHS, Biostatistics (1987) and a PhD (1989) Epidemiology from Johns Hopkins School of Public Health.

Co-founder and co-director, along with John Ioannidis, of the Meta-Research Innovation Center at Stanford (METRICS).

Awards

Works

He has made numerous contributions to meta analysis.[3][4][5][6][7][8][9][10][11][12][13][14] in addition to works on scientific evidence.[15][16][17][18][19][20][21][22][23][24][25][26][27][28]

References

  1. ↑ "Steven Goodman".
  2. ↑ Sellke, Thomas; Bayarri, M. J; Berger, James O (February 2001). "Calibration of ρ Values for Testing Precise Null Hypotheses". The American Statistician. 55 (1): 62–71. doi:10.1198/000313001300339950.
  3. ↑ Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., Goodman, S. N. (2014). "Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change.". Annals of Internal Medicine. 160 (4): 267–270. doi:10.7326/M13-2886.
  4. ↑ Basch, E., Aronson, N., Berg, A., Flum, D., Gabriel, S., Goodman, S. N., Helfand, M., Ioannidis, J. P., Lauer, M., Meltzer, D., Mittman, B., Newhouse, R., Normand, S., Schneeweiss, S., Slutsky, J., Tinetti, M., Yancy, C. (2012). "Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective". JAMA. 307 (15): 1636–1640. doi:10.1001/jama.2012.466.
  5. ↑ Goodman, S. N. (2012). "Quasi-random reflections on randomized controlled trials and comparative effectiveness research". Clinical Trials. 9 (1): 22–26. doi:10.1177/1740774511433285.
  6. ↑ Sox, H. C., Goodman, S. N. (2012). "The Methods of Comparative Effectiveness Research". Annual Review of Public Health. 33: 425–445. doi:10.1146/annurev-publhealth-031811-124610.
  7. ↑ Goodman, S., Dickersin, K. (2011). "Metabias: A Challenge for Comparative Effectiveness Research". Annals of Internal Medicine. 155 (1): 61-U104. doi:10.1059/0003-4819-155-1-201107050-00010.
  8. ↑ Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., Schwartz, J. S. (2009). "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change". Annals of Internal Medicine. 151 (3): 206-W45. doi:10.7326/0003-4819-151-3-200908040-00126.
  9. ↑ Goodman SN, Greenland S (2007). "Assessing the unreliability of the medical literature: A response to "Why most published research findings are false"".
  10. ↑ Goodman, S. N. (2002). "The mammography dilemma: A crisis for evidence-based medicine?". Annals of Internal Medicine. 137 (5): 363–365. doi:10.7326/0003-4819-137-5_part_1-200209030-00015.
  11. ↑ Goodman, S. N., Zahurak, M. L., PIANTADOSI, S. (1995). "SOME PRACTICAL IMPROVEMENTS IN THE CONTINUAL REASSESSMENT METHOD FOR PHASE-I STUDIES". Statistics in Medicine. 14 (11): 1149–1161. doi:10.1002/sim.4780141102.
  12. ↑ Goodman, S. N., Berlin, J. A. (1994). "THE USE OF PREDICTED CONFIDENCE-INTERVALS WHEN PLANNING EXPERIMENTS AND THE MISUSE OF POWER WHEN INTERPRETING RESULTS". Annals of Internal Medicine. 121 (3): 200–206. doi:10.7326/0003-4819-121-3-199408010-00008.
  13. ↑ Goodman, S. N. (1989). "META-ANALYSIS AND EVIDENCE". Controlled Clinical Trials. 10 (2): 188–204. doi:10.1016/0197-2456(89)90030-5.
  14. ↑ Goodman, S. N., Royall, R. (1988). "EVIDENCE AND SCIENTIFIC-RESEARCH". American Journal of Public Health. 78 (12): 1568–1574. doi:10.2105/ajph.78.12.1568.
  15. ↑ Glass, T. A., Goodman, S. N., Hernán, M. A., Samet, J. M. (2013). "Causal inference in public health.". Annual Review of Public Health. 34: 61–75. doi:10.1146/annurev-publhealth-031811-124606. PMC 4079266Freely accessible. PMID 23297653.
  16. ↑ Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics". Hastings Center Report. 43: S16-S27. doi:10.1002/hast.134.
  17. ↑ Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight". Hastings Center Report. 43: S4-S15. doi:10.1002/hast.133.
  18. ↑ Mello, M. M., Goodman, S. N., Faden, R. R. (2012). "Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report". New England Journal of Medicine. 367 (10): 959–964. doi:10.1056/NEJMhle1207160.
  19. ↑ Goodman, S. (2011). "Confessions of a chagrined trialist". BMJ Quality & Safety. 20: I97-I98. doi:10.1136/bmjqs.2010.046623.
  20. ↑ Goodman, S. N. (2007). "Stopping at nothing? Some dilemmas of data monitoring in clinical trials". Annals of Internal Medicine. 146 (12): 882–887. doi:10.7326/0003-4819-146-12-200706190-00010.
  21. ↑ Laine, C., Goodman, S. N., Griswold, M. E., Sox, H. C. (2007). "Reproducible research: Moving toward research the public can really trust". Annals of Internal Medicine. 146 (6): 450–453. doi:10.7326/0003-4819-146-6-200703200-00154.
  22. ↑ Goodman, S. N., Sladky, J. T. (2005). "A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain–Barre syndrome". Clinical Trials. 2 (4): 305–310. doi:10.1191/1740774505cn102oa.
  23. ↑ Goodman, S. N. (2001). "Of P-values and bayes: A modest proposal". Epidemiology. 12 (3): 295–297. doi:10.1097/00001648-200105000-00006.
  24. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 1: The P value fallacy". Annals of Internal Medicine. 130 (12): 995–1004. doi:10.7326/0003-4819-130-12-199906150-00008. PMID 10383371.
  25. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 2: The Bayes factor". Annals of Internal Medicine. 130 (12): 1005–1013. doi:10.7326/0003-4819-130-12-199906150-00019. PMID 10383350.
  26. ↑ Goodman, S. N., Berlin, J., Fletcher, S. W., Fletcher, R. H. (1994). "MANUSCRIPT QUALITY BEFORE AND AFTER PEER-REVIEW AND EDITING AT ANNALS OF INTERNAL-MEDICINE". Annals of Internal Medicine. 121 (1): 11–21. doi:10.7326/0003-4819-121-1-199407010-00003.
  27. ↑ Goodman, S. N. (1993). "P-VALUES, HYPOTHESIS TESTS, AND LIKELIHOOD - IMPLICATIONS FOR EPIDEMIOLOGY OF A NEGLECTED HISTORICAL DEBATE". American Journal of Epidemiology. 137 (5): 485–496.
  28. ↑ Goodman, S. N. (1992). "A COMMENT ON REPLICATION, P-VALUES AND EVIDENCE". Statistics in Medicine. 11 (7): 875–879. doi:10.1002/sim.4780110705.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.